Skip to content
Home/Companies/Healthcare/CALYSENS

CALYSENS

Healthcare·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns CALYSENS?

CALYSENS is currently owned by OBRATORI, L'Occitane Group Ventures through Obratori (2019 vintage), since 2021.

Hand-verified · updated 2026-04-21

OBRATORI, L'Occitane Group Ventures
Investor
OBRATORI, L'Occitane Group Ventures
Obratori · 2019 · VC

Key facts

HQFrance
SectorHealthcare

More from Obratori

Other portfolio companies in the same fund.

Humble +
Humble +
Active
ConsumerFrance· 2024
Lazare Studio
Lazare Studio
Active
ConsumerFrance· 2024
Carton Vert
Carton Vert
Active
ClimateTechFrance· 2023
KohortPay
Active
FintechFrance· 2023
Zeliq
Zeliq
Active
SaaSFrance· 2023
FunCell
FunCell
Active
ClimateTechFrance· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Calysens

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Calysens?

4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Calysens.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue